A Malaysian national arrested by the Directorate of
Revenue Intelligence for smuggling human embryos could spill the beans on a
thriving multi-crore international racket
The Directorate of Revenue Intelligence (DRI) that
is used to all kinds of smuggling—from gold to jewellery to drugs—increasingly
has to deal with smuggling of a different kind of cargo. Last week, the agency
began probing an alleged case of smuggling of human embryos after Partheban
Durai, a Malaysian national, was arrested at Mumbai International Airport on
his arrival from Kuala Lumpur on March 15 with a nitrogen canister containing a
single human embryo tucked inside his suitcase.
On questioning, Durai admitted to bringing embryos
to Mumbai at least eight to nine times in the past. In the present case, he was
allegedly scheduled to deliver the embryo at Indo Nippon Clinic, Bandra, run by
embryologist Goral Gandhi. The clinic has so far denied any involvement in the
fiasco. The DRI will be conducting a forensic analysis of the seized embryo to
establish its nationality and of the DNA to identify the parents.
Import of embryo, ovum and sperm is prohibited in
India except for research purposes since 2015. An Indian Council of Medical
Research (ICMR) guideline to permit regulated import is under the consideration
of the Union government. The Ministry of Commerce and Industry, vide a
Directorate General of Foreign Trade (DGFT) notification dated October 26, 2015,
on the subject, said: “Amendment in import policy of Human Embryo classified
under Exim Code 0511 99 99 of Chapter 05 of ITC (HS),
2012–Sche dule–1 (Import Policy) changed the
existing policy of “import of Human Embryo will be free subject to a ‘No Objection
Certificate’ from the Indian Council of Medical Research” to revised policy
“Import of Human Embryo is ‘Prohibited’ except for research purposes based on
the guidelines of the Department of Health Research.”
Durai, who claims to work for Heart to ART IVF
centre in Malaysia, was obviously not transporting the embryos for research
purposes. The Malaysia centre was registered two years ago in Selangor to
exclusively provide surrogacy services and services related to egg donors,
surrogate mothers and sperm donors, along with IVF services. Investigators
believe he was illegally importing fertilised eggs to be implanted in the wombs
of surrogate mothers. In India, the demand for surrogate pregnancies through
the commodification of women’s bodies has created a thriving market due to the
low costs involved.
All this raises the question: what is a single
embryo transfer? The most effective method of avoiding high-order multiple
pregnancies is single embryo transfer in IVF. Elective single embryo transfer
(eSET) is defined as transfer of one good quality embryo in cases in which at
least two good quality embryos are available. Practice committee guidelines of
the Society of Assisted Reproductive Technology and the American Society for
Reproductive Medicine suggest that eSET is most appropriate for women with a
good prognosis for conception: (a) age <35 years; (b) more than one
high-quality embryo for transfer; (c) first or second IVF treatment cycle; and
(d) recipients of embryos from donated eggs.
Oocyte (egg) donation is an integral part of modern
assisted reproductive care and is associated with the highest success rates.
Originally offered to women with primary ovarian insufficiency (premature
ovarian failure) or those who had genetic diseases and did not want to transmit
the gene defect to their offspring, donated oocytes are now used by women with
many reproductive disorders and commonly by women in later reproductive years.
Approximately 20,000 attempts at pregnancy using in vitro fertilisation (IVF)
with donated oocytes or embryos are initiated annually in the United States
alone.
It is widely believed that Malaysian couples may be
exporting their embryos for illegal surrogacy in India because of the country’s
strict Islamic laws. Surrogacy is banned in India for international couples and
exit visas for the newborns are not allowed. Indian couples, with permission,
may get the embryo frozen in western countries and then bring it to India for
implant provided they can prove that the same was not done with the sole
intention to get a male child.
Durai was, in all likelihood, importing the embryo
into India for commercial purposes, which is an illegal act in India. In
December 2018, the Lok Sabha passed the Surrogacy Bill, 2018, which regulates
altruistic surrogacy and prohibits commercial surrogacy and import of embryos.
Surrogacy means a practice whereby one woman bears
and gives birth to a child for an intending couple with the intention of
handing over such child to the intending couple after its birth. A gestational
carrier is a woman who agrees to carry a genetically unrelated child on behalf
of another individual or couple (intended parent[s]). The intended mother
provides the egg and the intended father provides the sperm; rarely, egg donors
or sperm donors are involved. In-vitro fertilisation (IVF) is used to create an
embryo, which is transferred into the uterus of the gestational carrier. In
countries which allow gestational carrier pregnancy, acceptable indications
vary but generally include absent or non-functioning uterus, medical conditions
that preclude safe pregnancy, and established inability to either conceive
and/or carry a pregnancy.
As per the Surrogacy Bill, 2018, “altruistic
surrogacy” means surrogacy in which no charges, expenses, fees, remuneration or
monetary incentive of whatever nature, except the medical expenses incurred on
the surrogate mother and the insurance coverage for the surrogate mother, are
given to the surrogate mother or her dependants or her representative. On the other
hand, the Bill defines “commercial surrogacy” as commercialisation of surrogacy
services or procedures or its component services or component procedures
including selling or buying of human embryo or trading in the sale or purchase
of human embryo or gametes or selling or buying or trading the services of
surrogate motherhood by way of giving payment, reward, benefit, fees,
remuneration or monetary incentive in cash or kind, to the surrogate mother or
her dependants or her representative, except the medical expenses incurred on
the surrogate mother and the insurance coverage for the surrogate mother.
Under the Bill, the following acts fall under the
category of punishable offences: (1) commercial surrogacy; (2) selling human
embryo for the purpose of surrogacy; and (3) import of embryo for surrogacy.
Further, the import of embryos for surrogacy is a punishable offence with
imprisonment upto 10 years and fine upto Rs10 lakh. Durai was importing the
embryo, not for research purposes, and without a “no objection certificate”
from the ICMR. His fate will be known when the Bombay HC takes up the matter on
April 3.
Reproduced from: India Legal, Published April 8, 2019: pg
32-33.
Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of
Medical Associations in Asia and Oceania
(CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of
India
Past National President
IMA
No comments:
Post a Comment